Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial
Byron Lam and collaborators at the University of Miami reported results from an 8-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy. They found no significant safety concerns; however,...
7-Jun-2022 5:05 PM EDT
Add to Favorites
NIH study confirms benefit of supplements for slowing age-related macular degeneration
The AREDS2 dietary supplement formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original AREDS formula.
2-Jun-2022 12:20 PM EDT
Add to Favorites
Retinal Cell Map Could Advance Precise Therapies for Blinding Diseases
Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) discovered five subpopulations of retinal pigment...
6-May-2022 3:50 PM EDT
Add to Favorites
Vision improvement is long-lasting with treatment for blinding blood vessel condition
New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment.
21-Apr-2022 10:05 AM EDT
Add to Favorites
Advancing a Treatment for a Common Eye Disease That Lacks One
The road from discovering a potential drug to getting the therapy into the hands of patients is a long and uncertain one. An NIH program offers researchers a smoother path from basic science to clinical testing and regulatory approval.
11-Apr-2022 11:05 AM EDT
Add to Favorites
Attention to objects in peripheral vision is not driven by tiny eye movements
New research by National Eye Institute (NEI) investigators shows that while microsaccades seem to boost or diminish the strength of brain signals underlying attention, the eye movements are not drivers of those brain signals.
25-Mar-2022 2:00 PM EDT
Add to Favorites
NIH study classifies vision loss and retinal changes in Stargardt disease
National Eye Institute researchers developed and validated an artificial-intelligence-based method to evaluate patients with Stargardt, an eye disease that can lead to childhood vision loss. The method quantifies disease-related loss of...
25-Jan-2022 12:30 PM EST
Add to Favorites
NIH researchers identify potential AMD drugs with stem-cell based research tool
Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the National Eye Institute...
14-Dec-2021 6:15 PM EST
Add to Favorites
See All News
NEI Highlights Cell and Gene Therapies, Novel Imaging Technologies at Vision Research Meeting
The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016).
29-Apr-2016 10:05 AM EDT
Hopkins Vision Researcher Links Environmental Change to Eye Health Hazards
Another reason to worry about climate change: Expanding areas of arid land, air pollution, and greater exposure to ultraviolet (UV) radiation all present potential health hazards to your eyes, according to Sheila West, Ph.D., vice chair for research...
8-Dec-2015 3:30 PM EST
Dr. Emily Chew of #NIH Is Available to Talk About Macular Degeneration
21-Apr-2015 11:05 AM EDT
See All Experts